tegafur

Tegafur (FT 207) is a congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the liver by the cytochrome P-450 enzyme.

Tegafur-Uracil is able to be used for anti solid tumors research that is an orally active fluoropyrimidines anticancer agent. Tegafur-Uracil inhibits synthase of thymidylate [1].

Tegafur-gimeracil-oteracil potassium (TS-1) is a complex composed of Tegafur, Gimeracil, and Oteracil potassium in a molar ratio of 1:0.4:1. TS-1 is an orally active anticancer agent containing a fluoropyrimidine antagonist and a 5-FU modulator, primarily used in the study of metastatic cancers.

Tegafur (Standard) is a reference standard for research and analysis in studies involving Tegafur. Tegafur (FT 207) is a congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the liver by the cytochrome P-450 enzyme.